Director, Seung-ju Lee

Board-Certified Dermatologist

Director, Seung-ju Lee

Clinic Schedule

AM/PMMonTueWedThuFriSatSun
AMOpenOpenOpenClosedOpenOpenOpen
PMOpenOpenOpenClosedOpenOpenOpen
Hours
Mon/Tue/Wed/Fri AM 10:00 ~ PM 07:30 (no lunch break)Sat/Sun AM 10:00 ~ PM 05:00Closed Thursdays and public holidays
Book a consultation

Education & Career

  • M.D., Yonsei University College of Medicine
  • M.S, Graduate School of Yonsei University College of Medicine
  • Dermatology Residency, Gangnam Severance Hospital, Yonsei University Health System
  • Board-Certified Dermatologist, Gangnam Severance Hospital, Yonsei University Health System
  • Visiting Student, Fudan University (China)
  • Visiting Student, Keio University (Japan)
  • Clinical Clerkship, Emory University Hospital (USA)
  • Former Official Dermatologist & Medical Consultant to the President of South Korea
  • Former Chief of Dermatology, Seoul District Hospital, Medical Office of the Office of the President
  • Highest Honors Award, Yonsei University College of Medicine
  • Best Resident Award, Gangnam Severance Hospital
  • Outstanding Resident Research Award, Gangnam Severance Hospital
  • Former Medical Director, Irvine Dermatology Clinic
  • Best Poster Award, Autumn Meeting of the Korean Dermatological Association
  • Best Oral Presentation Award, Spring Meeting of the Korean Dermatological Association
  • Best Paper Award, Korean Journal of Dermatology
  • Best Poster Award, Korean Society for Investigative Dermatology
  • Full Member, Korean Dermatological Association
  • Full Member, Association of Korean Dermatologists
  • Full Member, Korean Society for Clinical Dermatologic Treatment
  • Full Member, Korean Society for Dermatologic Anti-aging
  • Full Member, Korean Academy of Aesthetic Dermatology

Publications

  • 1. Distinct signatures of cutaneous microbiome associated with disease severity in Hailey–Hailey disease J Eur Acad Dermatol Venereol 2025;39(3):e266-e268
  • 2. Clinical Course and Long-Term Prognosis of Patients with Recessive Dystrophic Epidermolysis Bullosa in Korea: A Longitudinal, Retrospective Single-Center Study Korean J Dermatol 2022;60(1):7-15
  • 3. Clinical outcome and B-cell kinetics in intercellular immunoglobulin A dermatosis treated with rituximab J Dermatol 2022;49(1):e22-e23
  • 4. Improvement of dysbiosis in patients with atopic dermatitis treated with dupilumab correlates with increased stratum corneum hydration Allergy Asthma Immunol Res 2021;13(4)
  • 5. Invasive Cutaneous Squamous Cell Carcinoma Arising from Chronic Hidradenitis Suppurativa: A Case Report of Treatment by Slow Mohs Micrographic Surgery Ann Dermatol 2021;33(1):68-72
  • 6. Intravenous allogeneic umbilical cord blood–derived mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa patients JCI Insight 2021;6(2):e143606
  • 7. Childhood granulomatous periorificial dermatitis with extrafacial involvement treated with oral azithromycin and topical pimecrolimus: A case report Korean J Dermatol 2020;58(5)
  • 8. Compound Heterozygous Mutations with a Novel Variant in Integrin Beta4 Cause Epidermolysis Bullosa with Pyloric Atresia and Urologic Abnormalities Yonsei Med J 2020;61(9):831-833

← Medical Staff